Ketoacidosis in diabetic subjects treated with inhibitors of Na(+)-glucose co-transporters type-2: New mechanisms?
作者信息
Tessari Paolo
机构信息
Department of Medicine, Metabolism Unit, University of Padua, 35128 Padova, Italy.
出版信息
Indian J Endocrinol Metab. 2016 Jul-Aug;20(4):576. doi: 10.4103/2230-8210.183465.
Abstract
摘要
相似文献
1
Ketoacidosis in diabetic subjects treated with inhibitors of Na(+)-glucose co-transporters type-2: New mechanisms?使用钠-葡萄糖协同转运蛋白2抑制剂治疗的糖尿病患者的酮症酸中毒：新机制？
Indian J Endocrinol Metab. 2016 Jul-Aug;20(4):576. doi: 10.4103/2230-8210.183465.
2
Canagliflozin-associated Diabetic Ketoacidosis with Lower-than-anticipated Glucose Levels.卡格列净相关的糖尿病酮症酸中毒伴血糖水平低于预期
Indian J Crit Care Med. 2017 Nov;21(11):793-795. doi: 10.4103/ijccm.IJCCM_328_17.
3
SGLT2 Inhibitors May Predispose to Ketoacidosis.钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂可能易引发酮症酸中毒。
J Clin Endocrinol Metab. 2015 Aug;100(8):2849-52. doi: 10.1210/jc.2015-1884. Epub 2015 Jun 18.
4
Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors - A Case Series.2型糖尿病患者使用钠-葡萄糖协同转运蛋白2抑制剂后的糖尿病酮症酸中毒——病例系列
Rev Recent Clin Trials. 2018;13(2):156-160. doi: 10.2174/1574887113666180314101436.
5
Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review.与钠-葡萄糖共转运蛋白 2 抑制剂相关的围手术期糖尿病酮症酸中毒：系统评价。
Br J Anaesth. 2019 Jul;123(1):27-36. doi: 10.1016/j.bja.2019.03.028. Epub 2019 May 3.
6
Metabolic ketoacidosis with normal blood glucose: A rare complication of sodium-glucose cotransporter 2 inhibitors.血糖正常的代谢性酮症酸中毒：钠-葡萄糖协同转运蛋白2抑制剂的一种罕见并发症。
SAGE Open Med Case Rep. 2016 Nov 24;4:2050313X16675259. doi: 10.1177/2050313X16675259. eCollection 2016.
7
Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectives.SGLT2抑制剂相关的酮症及糖尿病酮症酸中毒：基本机制与治疗前景
Diabetes Metab Res Rev. 2017 Jul;33(5). doi: 10.1002/dmrr.2886. Epub 2017 Feb 23.
8
Diabetic ketoacidosis, sodium glucose transporter-2 inhibitors and the kidney.糖尿病酮症酸中毒、钠-葡萄糖协同转运蛋白2抑制剂与肾脏
J Diabetes Complications. 2016 Aug;30(6):1162-6. doi: 10.1016/j.jdiacomp.2016.05.008. Epub 2016 May 10.
9
Euglycemic Diabetic Ketoacidosis in a 27 year-old female patient with type-1-Diabetes treated with sodium-glucose cotransporter-2 (SGLT2) inhibitor Canagliflozin.一名27岁1型糖尿病女性患者使用钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂卡格列净治疗后出现正常血糖性糖尿病酮症酸中毒。
Pak J Med Sci. 2016 May-Jun;32(3):786-8. doi: 10.12669/pjms.323.9201.
10
SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂：对原发性文献中糖尿病酮症酸中毒及相关危险因素的系统评价
Pharmacotherapy. 2017 Feb;37(2):187-194. doi: 10.1002/phar.1881. Epub 2017 Jan 16.
本文引用的文献
1
Sodium glucose transporter 2 (SGLT2) inhibition and ketogenesis.钠-葡萄糖协同转运蛋白2（SGLT2）抑制作用与生酮作用。
Indian J Endocrinol Metab. 2015 Jul-Aug;19(4):524-8. doi: 10.4103/2230-8210.157859.
2
SGLT2 Inhibitors May Predispose to Ketoacidosis.钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂可能易引发酮症酸中毒。
J Clin Endocrinol Metab. 2015 Aug;100(8):2849-52. doi: 10.1210/jc.2015-1884. Epub 2015 Jun 18.
3
Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.2 型糖尿病患者对钠-葡萄糖共转运蛋白 2 抑制剂的代谢反应。
J Clin Invest. 2014 Feb;124(2):499-508. doi: 10.1172/JCI72227. Epub 2014 Jan 27.
4
Human cardiomyocytes express high level of Na+/glucose cotransporter 1 (SGLT1).人类心肌细胞表达高水平的钠/葡萄糖协同转运蛋白1（SGLT1）。
J Cell Biochem. 2003 Oct 1;90(2):339-46. doi: 10.1002/jcb.10631.
5
Ketone body metabolism in normal and diabetic human skeletal muscle.正常及糖尿病患者骨骼肌中的酮体代谢
Am J Physiol. 1985 Aug;249(2 Pt 1):E131-6. doi: 10.1152/ajpendo.1985.249.2.E131.
6
Antiketogenic effect of glucose per se in vivo in man and in vitro in isolated rat liver cells.葡萄糖在人体体内及离体大鼠肝细胞体外实验中的抗生酮作用。
Metabolism. 1986 Jul;35(7):608-13. doi: 10.1016/0026-0495(86)90165-4.
Zotero 插件